Welcome to our dedicated page for Fidelity National Financial SEC filings (Ticker: FNF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Fidelity National Financial's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Fidelity National Financial's regulatory disclosures and financial reporting.
Fidelity National Financial (FNF) reported an insider equity award on a Form 4. A director acquired 4,870 shares of common stock on 11/10/2025 at a stated price of $0, reflecting a grant of restricted common stock. Following this transaction, the reporting person beneficially owned 235,439 shares, held directly.
The grant vests in three equal annual installments beginning on November 10, 2026. The filing was made by one reporting person and reflects a routine equity compensation award.
Fidelity National Financial (FNF) reported a director’s acquisition of 4,870 shares of common stock on 11/10/2025. The filing notes this was a grant of restricted common stock at $0 per share, vesting in three equal annual installments beginning November 10, 2026.
Following the grant, the director beneficially owns 17,545 shares, held directly. This is a routine equity award aligning director compensation with shareholder interests through time-based vesting.
Fidelity National Financial (FNF) reported an insider equity award. A director acquired 4,870 shares of common stock on November 10, 2025 at $0, reflecting a grant of restricted stock.
The award vests in three equal annual installments beginning on November 10, 2026. Following the grant, the director directly owns 41,620 shares of FNF common stock.
Fidelity National Financial (FNF) disclosed an insider equity award. A director acquired 4,870 shares of common stock on 11/10/2025 at $0 as a grant of restricted stock, which vests in three equal annual installments beginning on November 10, 2026.
Following this grant, the director beneficially owns 282,675 shares, reported as directly held.
Fidelity National Financial (FNF) reported an insider equity award. A company director received a grant of 4,870 shares of restricted common stock on November 10, 2025, at a stated price of $0.
The award vests in three equal annual installments beginning on November 10, 2026. Following this transaction, the reporting person beneficially owned 349,511.6 shares, held directly.
Fidelity National Financial (FNF) reported a director equity grant. On 11/10/2025, the director received 4,870 shares of common stock at $0 as restricted stock, vesting in three equal annual installments beginning on 11/10/2026. Following the grant, the director beneficially owned 19,186 shares, held directly. This reflects routine equity compensation disclosed on a Form 4.
Fidelity National Financial (FNF) reported an insider equity grant. A director acquired 4,870 shares of common stock on 11/10/2025 as a restricted stock award priced at $0. Following the transaction, the director beneficially owns 149,340.553 shares, held directly.
The award vests in three equal annual installments beginning on November 10, 2026.
Fidelity National Financial (FNF) reported an equity award to its EVP, Chief Legal Officer. On 11/10/2025, the officer acquired 29,218 shares of restricted common stock at $0. The award vests in three equal annual installments beginning 11/10/2026, subject to performance criteria in the award agreement.
Following the grant, directly held common stock was 195,026.988 shares. Indirect holdings included 2,606.07 shares in a 401(k) account, 473 shares in an IRA, and 74,898 shares in a trust.
Fidelity National Financial (FNF) reported an insider equity grant on a Form 4. The reporting person, a Director and Executive Vice‑Chairman, acquired 55,653 shares of restricted common stock on 11/10/2025 at $0 under transaction code A.
The award vests in three equal annual installments beginning November 10, 2026, subject to performance criteria in the award agreement. Following the transaction, beneficial holdings were 200,387.2675 shares direct, plus 565.2 indirect via a 401(k) account and 2,150,955 indirect via the Quirk 2002 Trust.
Fidelity National Financial (FNF) reported an insider equity grant by its EVP & Chief Financial Officer. On 11/10/2025, the officer acquired 31,044 shares of common stock at $0, reflecting a grant of restricted stock. These shares vest in three equal annual installments beginning November 10, 2026, subject to performance criteria in the award agreement.
Following the transaction, beneficial ownership stands at 140,327.3516 shares direct, plus indirect holdings of 272,759 shares via the Park Family Trust and 3.11 shares in a 401(k) account.